"The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?
- PMID: 12488404
- DOI: 10.1200/JCO.2002.20.24.4618
"The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?
Comment on
-
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.J Clin Oncol. 2002 Dec 15;20(24):4665-72. doi: 10.1200/JCO.2002.12.111. J Clin Oncol. 2002. PMID: 12488411 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
